Xtrackers Russell 2000 Comprehensive Factor ETF (DESC) News Today

$34.71
+0.05 (+0.14%)
(As of 11/12/2019)
No headlines for this company have been tracked by MarketBeat.com

Get Xtrackers Russell 2000 Comprehensive Factor ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for DESC and its competitors with MarketBeat's FREE daily newsletter.

The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>

DESC Media Mentions By Week

DESC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DESC
News Sentiment

0.00

0.45

Average
Miscellaneous
News Sentiment

DESC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DESC Articles
This Week

0

0

DESC Articles
Average Week

Get Xtrackers Russell 2000 Comprehensive Factor ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for DESC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
This page (NYSEARCA:DESC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners